Sjogren's Syndrome: all 381 studies
Page 2 of 4. Open to participants first (106), then studies with results posted, then the rest; newest registration first within each.
- The ASSESS National Multi-center Prospective CohortRecruitingNCT03040583
- Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease ActivityRecruitingNCT03003572
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- Characterization of Diseases With Salivary Gland InvolvementRecruitingNCT02327884
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT01793168
- The Pathogenesis and Natural History of Sjogren's DiseaseRecruitingNCT01425892
- Nasal Spray Study in Sjogren's Dry Eye DiseaseCompletedNCT05700422Phase 4Results posted
- A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)TerminatedNCT04988087Phase 2Results posted
- A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS)TerminatedNCT04700280Phase 2Results posted
- Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE FittingCompletedNCT04649177Not applicableResults posted
- Efficacy and Safety of S95011 in Primary Sjögren's Syndrome PatientsCompletedNCT04605978Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)CompletedNCT04572841Phase 2Results posted
- Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's SyndromeCompletedNCT04541589Phase 2Results posted
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's SyndromeActive, not recruitingNCT04496960Phase 1/2Results posted
- Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisCompletedNCT04186871Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's SyndromeCompletedNCT04129164Phase 2Results posted
- Pilot Trial of Ustekinumab for Primary Sjögren's SyndromeCompletedNCT04093531Phase 1Results posted
- A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's SyndromeTerminatedNCT04035668Phase 2Results posted
- Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's SyndromeCompletedNCT03905525Phase 2Results posted
- TrueTear in Sjogren's Disease PatientsCompletedNCT03719885Not applicableResults posted
- A Study of INCB050465 in Primary Sjögren's SyndromeCompletedNCT03627065Phase 2Results posted
- RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)CompletedNCT03445650Phase 3Results posted
- A Study of RSLV-132 in Subjects With Primary Sjogren's SyndromeCompletedNCT03247686Phase 2Results posted
- Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's SyndromeCompletedNCT03100942Phase 2Results posted
- Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)CompletedNCT02962895Phase 2Results posted
- A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens SyndromeCompletedNCT02915159Phase 3Results posted
- Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's SyndromeTerminatedNCT02843659Phase 2Results posted
- e-Mobile Tablet for People With Chronic ConditionsCompletedNCT02833311Not applicableResults posted
- Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's SyndromeCompletedNCT02775916Phase 2Results posted
- A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's SyndromeCompletedNCT02701985Phase 2Results posted
- LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for LeukodystrophiesCompletedNCT02699190Results posted
- Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's SyndromeCompletedNCT02631538Phase 2Results posted
- A Study of Topical NS2 Cream to Treat Ichthyosis in Sjögren-Larsson Syndrome (SLS)CompletedNCT02402309Phase 2Results posted
- A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's SyndromeCompletedNCT02334306Phase 2Results posted
- Evaluation of Ocular Surface Inflammatory Mediators Effected by LotemaxCompletedNCT02322528Not applicableResults posted
- Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's SyndromeCompletedNCT02291029Phase 2Results posted
- Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry EyeCompletedNCT02257957Phase 3Results posted
- PD of VAY736 in Patients With Primary Sjögren's SyndromeCompletedNCT02149420Phase 2Results posted
- Laser Therapy to Treat the Dry Mouth of Sjogren's SyndromeCompletedNCT02066896Not applicableResults posted
- Green Tea Lozenges for the Management of Dry MouthCompletedNCT01647737Phase 1/2Results posted
- Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's SyndromeTerminatedNCT01552681Phase 2Results posted
- Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry EyeCompletedNCT01393132Phase 2Results posted
- Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome SubjectsTerminatedNCT01316770Phase 2Results posted
- Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid InterventionCompletedNCT00631358Phase 4Results posted
- Pilot Study of Raptiva to Treat Sjogren's SyndromeTerminatedNCT00344448Phase 2Results posted
- Exploratory Study for Dry Mouth in Patients With Sjögren's SyndromeCompletedNCT00233363Phase 2Results posted
- The Effect of Telerehabilitation Based Physical Activity Training Associated With Single and Dual Task Training on Physical and Cognitive Functions in Individuals With Primary Sjögren's SyndromeActive, not recruitingNCT07833644Not applicable
- a Salivary Cell-free RNA Liquid Biopsy Model for Non-invasive Diagnosis in Sjögren's DiseaseCompletedNCT07824440
- A Study of BEN301 Injection in theTreatment of Autoimmune DiseasesSuspendedNCT07527936Early Phase 1
- Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)CompletedNCT07469865Not applicable
- Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07361094Phase 1
- "Validity and Reliability of Pelvic Floor Distress Inventory-20 in Primary Sjögren's Syndrome"CompletedNCT07248436
- Temporomandibular Joint Dysfunction in Sjögren's SyndromeCompletedNCT07248306
- Current Therapy in Primary Sjogren's SyndromeCompletedNCT06989411Not applicable
- Artificial Intelligence Based Models for Primary Sjögren's Syndrome DiagnosisCompletedNCT06982482
- Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye.CompletedNCT06931041Phase 3
- Photodynamic Treatment as Part of Oral Healthcare on Persons With Sjögren's SyndromeActive, not recruitingNCT06877546Not applicable
- Nipocalimab in Moderate to Severe Sjogren's DiseaseActive, not recruitingNCT06741969Phase 3
- The Feasibility of Multispectral Optoacoustic Tomography in Different DiseasesCompletedNCT06740175Not applicable
- Intra-Nasal Mechanical Stimulation (INMEST) as a Potential Treatment Method for Sjogren's Syndrome (SS)CompletedNCT06626477Not applicable
- Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune DiseasesSuspendedNCT06549296Early Phase 1
- A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's SyndromeTerminatedNCT06544642Phase 1
- A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's DiseaseTerminatedNCT06531395Phase 2
- An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's SyndromeCompletedNCT06437652
- Acupuncture Combined With HydroxychloroquineCompletedNCT06432101Not applicable
- Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWithdrawnNCT06411639Phase 1
- Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry EyeTerminatedNCT06411132
- Comprehensive Evaluation of Clinical and Biopsychosocial Characteristics in Primary Sjögren's DiseaseCompletedNCT06410742
- Investigation of the Effectiveness of Cognitive Exercise Therapy Approach in Patients With Primary Sjögren's SyndromeCompletedNCT06398210Not applicable
- Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry EyeTerminatedNCT06364657
- Assessing the Efficacy of a Carbamide Peroxide Mouthwash for Oral Wound Healing, Oral Hygiene and Xerostomia ReliefCompletedNCT06363955Not applicable
- Ro60 Expression in Macrophages in Sjogren's DiseaseActive, not recruitingNCT06324968Not applicable
- A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeTerminatedNCT06312020Phase 2
- A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom StateActive, not recruitingNCT06245408Phase 3
- A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease ActivityCompletedNCT06104124Phase 3
- AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry EyeCompletedNCT06013436
- A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.Active, not recruitingNCT05985915Phase 3
- Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory RheumatismCompletedNCT05961267
- A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeActive, not recruitingNCT05946941Phase 3
- AONDA Therapeutic Indication Study ICompletedNCT05891106
- Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic DiseasesActive, not recruitingNCT05879419Phase 4
- Rheumatology-based Adaptive Intervention for Social Determinants and Health EquityActive, not recruitingNCT05715463Not applicable
- Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
- Superb Microvascular Imaging Ultrasonography of Lacrimal Gland in Patients With Sjögren SyndromeCompletedNCT05689749
- The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's SyndromeCompletedNCT05680064Not applicable
- Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
- Sjögren and Gynecologic ConsiderationsCompletedNCT05670535
- VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's SyndromeCompletedNCT05656196Not applicable
- Wheat-free Diet in the Treatment of Sjogren's SyndromeCompletedNCT05644795Not applicable
- HRR as a Novel Biomarker in Sjögren's SyndromeCompletedNCT05633524
- Low-dose Interleukin-2 and Rapamycin on sjögren's SyndromeCompletedNCT05605665Phase 1/2
- Amniotic Membrane Treatment for Hyposecretory Dry EyeCompletedNCT05598242Phase 3
- Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic SclerosisCompletedNCT05528809Not applicable
- Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's SyndromeStatus unknownNCT05383677Phase 2
- Cutaneous Silent Period Assessment in Primary Sjögren's SyndromeCompletedNCT05380804
- Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeCompletedNCT05350072Phase 3
- Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's SyndromeActive, not recruitingNCT05349214Phase 3
- Polymyalgia Rheumatica Associated to Primary Sjogren SyndromeStatus unknownNCT05312944
- Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's SyndromeCompletedNCT05269810Phase 2
- An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)WithdrawnNCT05217472Phase 2